Talk One: Recent challenges and opportunities in Downstream processing
Confirmed speaker: Yan-Ping Yang, Head of Bioprocess Research & Development, North America, Sanofi Pasteur
Talk 2: Process development for a flexible vaccine vector platform based on recombinant life virus
Confirmed speaker: Dieter Palmberger, Senior Scientist, acib - Austrian Centre of Industrial Biotechnology, Austria
Talk 3: Development of different delivery platforms for Biologics
- Unlike conventional formulation development, delivery platform and late stage formulation focus more on the control of delivery technology for dosage forms. Conditions to keep the desired potency of drug/biologic before and during the administration is equally important.
- Poor delivery platform will causes significant potency loss of drug/biologic during the administration no matter how great of shelf-life the product has.
- Scientists working in the formulation field should consider the delivery route as a critical factor in developing their product and design the formulation and delivery study to support it or could see failure in the animal study, clinical study and impact the future of the project
Confirmed speaker: Amish Patel, Senior Director, Product Development, PaxVax, USA